相似文献
1
Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist.
Am J Hematol. 2022 Jan 1;97(1):119-128. doi: 10.1002/ajh.26384. Epub 2021 Nov 8.
2
A review on how to do hematology consults during COVID-19 pandemic.
Blood Rev. 2021 May;47:100777. doi: 10.1016/j.blre.2020.100777. Epub 2020 Nov 8.
3
Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT).
Br J Haematol. 2021 Nov;195(3):299. doi: 10.1111/bjh.17619. Epub 2021 Jul 9.
4
Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.
Hematology. 2021 Dec;26(1):225-239. doi: 10.1080/16078454.2021.1881225.
5
Hematological Abnormalities in COVID-19: A Narrative Review.
Am J Trop Med Hyg. 2021 Feb 19;104(4):1188-1201. doi: 10.4269/ajtmh.20-1536.
6
Long-term complications of COVID-19.
Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1-C11. doi: 10.1152/ajpcell.00375.2021. Epub 2021 Nov 24.
7
COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome.
Eur J Haematol. 2021 Aug;107(2):173-180. doi: 10.1111/ejh.13665. Epub 2021 Jun 9.
8
Thrombocytopenia and thrombosis in hospitalized patients with COVID-19.
J Hematol Oncol. 2020 Dec 1;13(1):161. doi: 10.1186/s13045-020-01003-z.
9
Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care.
Med Sci Monit. 2021 Jun 7;27:e933446. doi: 10.12659/MSM.933446.
10
Post-COVID-19 hematologic complications: a systematic review.
Expert Rev Hematol. 2022 Jun;15(6):539-546. doi: 10.1080/17474086.2022.2080051. Epub 2022 May 26.
引用本文的文献
1
Assessing the Burden of Thromboembolic Complications in Outpatient COVID-19 Cases: A Focused Study on Patients Followed in Primary Care.
Can J Infect Dis Med Microbiol. 2025 Jul 24;2025:7242450. doi: 10.1155/cjid/7242450. eCollection 2025.
2
The Role of N-terminal Pro-B-Type Natriuretic Peptide, Troponins, and D-dimer in Acute Cardio-Respiratory Syndromes: A Multi-specialty Systematic Review.
Cureus. 2025 May 20;17(5):e84460. doi: 10.7759/cureus.84460. eCollection 2025 May.
3
Cardiovascular Symposium on Perspectives in Long COVID.
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251319963. doi: 10.1177/10760296251319963.
4
Haematological Manifestations of SARS-CoV-2: Insights into Erythropoiesis, Hepcidin Regulation, and Cytokine Storm.
Int J Mol Sci. 2025 Jan 21;26(3):874. doi: 10.3390/ijms26030874.
5
Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parameters.
Infection. 2025 Jan 16. doi: 10.1007/s15010-024-02459-8.
6
Blood matters: the hematological signatures of Coronavirus infection.
Cell Death Dis. 2024 Nov 28;15(11):863. doi: 10.1038/s41419-024-07247-8.
7
SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplant.
Clin Hematol Int. 2024 Jul 26;6(3):33-37. doi: 10.46989/001c.121430. eCollection 2024.
8
Persistent Vascular Complications in Long COVID: The Role of ACE2 Deactivation, Microclots, and Uniform Fibrosis.
Infect Dis Rep. 2024 Jun 27;16(4):561-571. doi: 10.3390/idr16040042.
9
Effects of Pycnogenol® in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial.
Trials. 2024 Jun 15;25(1):385. doi: 10.1186/s13063-024-08187-6.
10
Case Report: Visceral Leishmaniasis Falsely Diagnosed as Viral Hepatitis C Without Febrile Symptoms.
Infect Drug Resist. 2024 May 20;17:2009-2014. doi: 10.2147/IDR.S456984. eCollection 2024.
本文引用的文献
1
Sars-CoV-2 Virus Infection May Interfere CD34+ Hematopoietic Stem Cells and Megakaryocyte-Erythroid Progenitors Differentiation Contributing to Platelet Defection towards Insurgence of Thrombocytopenia and Thrombophilia.
Microorganisms. 2021 Jul 30;9(8):1632. doi: 10.3390/microorganisms9081632.
2
Persistent endotheliopathy in the pathogenesis of long COVID syndrome.
J Thromb Haemost. 2021 Oct;19(10):2546-2553. doi: 10.1111/jth.15490. Epub 2021 Sep 12.
3
A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.
J Thorac Dis. 2021 May;13(5):2986-3000. doi: 10.21037/jtd-20-3011.
4
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.
Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22.
5
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.
J Infect. 2021 Jul;83(1):1-16. doi: 10.1016/j.jinf.2021.05.004. Epub 2021 May 14.
6
Delayed, transient and self-resolving neutropenia following COVID-19 pneumonia.
BMJ Case Rep. 2021 May 12;14(5):e242596. doi: 10.1136/bcr-2021-242596.
7
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.
Viruses. 2021 Apr 18;13(4):700. doi: 10.3390/v13040700.
8
Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8.
Eur J Emerg Med. 2021 Jun 1;28(3):218-226. doi: 10.1097/MEJ.0000000000000783.
9
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization.
Semin Thromb Hemost. 2021 Jun;47(4):362-371. doi: 10.1055/s-0041-1727284. Epub 2021 Apr 23.
10
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.
Blood. 2021 May 20;137(20):2838-2847. doi: 10.1182/blood.2020010529.
Zotero 插件